Apollo in talks to acquire J&J’s DePuy Synthes for around $20bn
Monday, September 14, 2026 · first reported by Private Equity Wire
Apollo Global Management in advanced talks to acquire Johnson & Johnson's DePuy Synthes orthopaedics business for ~$20bn; deal could close within weeks, with alternative spin-off option under consideration.
- Also named
- Johnson & Johnson, DePuy Synthes
- Deal value
- $20B
- Asset class
- Private equity
- Geography
- North America
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
1 sourceMore on Apollo Global Management
Everything on this firm →- Apollo, KKR seal €3bn Bayer reversible contraceptives deal; Aurelius agrees $323m Hain unit carve-outAltAssets
- Apollo provides $585m financing package to KKR-backed TECPrivate Equity Wire +1
- Apollo Closed a $9 Billion Minority Equity Investment in ONEOKHedgeCo Insights
- Apollo invests $1.25bn to back BMG and Concord mergerPE Hub +1
More in Deals
From the same day- Francisco Partners, KKR take minority stakes in TeamSystem at up to €10bn valuationPrivate Equity Wire +1
- Dell-Backed Group Taking Baldwin Private In $7.7B DealLaw360
- Waterland ends Giacom alliance but keeps Gamma takeover interest alivePrivate Equity Wire
- Aurelius agrees to buy Hain Celestial’s international business for $323mPE Hub
- Main Capital Partners agrees to take Tribal Group privatePE Hub +1
- KKR Pays $608M for 51% Stake in Realty Income European Net-Lease PortfolioCommercial Observer